Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial evaluating the anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (COPD) has been completed w…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 dose-ranging study of danirixin in COPD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Ig PRx in AECOPD: Pilot Study [Phase 2]
A Phase 2 pilot study of Ig PRx in acute exacerbation of chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Regulation of the Release of Inflammatory Mediators From Lung Macrophages.
Clinical trial studying regulation of inflammatory mediator release from lung macrophages in COPD and related conditions; completed with res…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1 [Phase 2]
Phase 2 pilot study assessing feasibility and safety of immunoglobulin treatment in outpatients with COPD and frequent exacerbations.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation [Phase 2]
Phase 2 trial evaluating inhaled GSK2269557 in COPD patients with acute exacerbation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Macrophage Phagocytosis in COPD
A completed clinical trial from Imperial College London investigating macrophage phagocytosis in COPD with results posted in 2019.
-
FDA approval · 2019-11-15FDA Approved: PREDNISONE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approves ANI Pharmaceuticals' original (generic) application for prednisone, enabling a generic prednisone product to be marketed.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 clinical trial evaluating TD-4208 effects on FEV1 in subjects with chronic obstructive pulmonary disease (COPD); results posted afte…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Airway Effects of Tiotropium in Patients With COPD [Phase 3]
A Phase 3 clinical trial evaluating the airway effects of tiotropium in patients with chronic obstructive pulmonary disease has completed an…
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 randomized study evaluating danirixin in COPD was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial assessing safety and efficacy of single doses of CHF 4226 pMDI in chronic obstructive pulmonary disease (COPD) completed.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Lung Health Study II [Phase 3]
Phase 3 clinical trial update for a lung health study focusing on obstructive lung diseases.
-
CLINICAL_TRIALS research · 2019-10-29Clinical Trial Update: Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) [NA]
Clinical trial evaluating interventions to teach inhaler technique in asthma and COPD; completed with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-10-21Clinical Trial Update: A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 clinical trial evaluating errors, training time, and preferences for the ELLIPTA Dry Powder Inhaler compared with other DPIs for tri…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD [NA]
Clinical trial evaluating post-discharge utilization for patients with acute exacerbation of COPD; study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis [Phase 3]
Phase 3 trial evaluating roflumilast for reducing exacerbations in non-cystic fibrosis bronchiectasis (with COPD overlap) has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD [Phase 2]
Phase 2 trial update evaluating the bronchodilator effect of RPL554 added to tiotropium/olodaterol in COPD patients; results posted after co…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency [Phase 3]
Phase 3 trial update for ARALAST NP and GLASSIA in alpha-1 antitrypsin deficiency (A1PI) has terminated; results posted.
-
CLINICAL_TRIALS research · 2019-10-03Clinical Trial Update: Sustainability of Pulmonary Rehab Gains [NA]
Clinical trial update on the sustainability of pulmonary rehabilitation gains in COPD patients with completed results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: OTIVACTO Spain Non Interventional Study
Non-interventional study update for OTIVACTO in Spain; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy
Completed clinical trial evaluating effectiveness and handling of Spiolto Respimat in COPD patients conducted in Italy.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients [Phase 4]
Phase 4 trial update assessing the effect of tiotropium + olodaterol on breathlessness in COPD patients; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug [Phase 1]
Phase 1 study evaluating safety and drug levels of inhalation powder CCI15106 in healthy adults and adults with moderate chronic obstructive…
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos) [Phase 3]
Phase 3 trial comparing PT009 with PT005 for COPD exacerbations over 52 weeks completed with posted results.